Biography
Dr. Zhou Kai is a distinguished Chief Oncologist at Xiangya Hospital, Central South University with 16 years of dedicated clinical practice. Over the course of an extensive career, Zhou Kai has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Zhou Kai specializes in the diagnosis and management of complex medical conditions, with particular expertise in Colorectal cancer, Targeted therapy, Lymphoma, CAR-T cell therapy. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Zhou Kai for the following conditions and procedures:
- Colorectal cancer
- Targeted therapy
- Lymphoma
- CAR-T cell therapy
Education & Training
- MD Shanghai Jiao Tong University · Fellowship MD Anderson Cancer Center
Professional Credentials & Memberships
- American Society of Clinical Oncology (ASCO) Affiliate
- Chinese Society of Clinical Oncology Member
- International Association for the Study of Lung Cancer
International Patient Care
Dr. Zhou Kai communicates with patients in English, Chinese, Japanese, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD Shanghai Jiao Tong University · Fellowship MD Anderson Cancer Center
Certifications
- American Society of Clinical Oncology (ASCO) Affiliate
- Chinese Society of Clinical Oncology Member
- International Association for the Study of Lung Cancer